Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Transplant Proc ; 48(2): 564-7, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27110003

ABSTRACT

In Mexico and globally, organs and/or tissues donated from deceased people are insufficient to cover the demand for transplants. In 2014, a rate of 3.6 organ donors per million in habitants was recorded; this is reflected in the transplants performed, including heart transplantation, with a rate of 0.4 per million population. According to the legal framework of Mexico, the National Transplant Center is responsible for coordinating National Subsystem of donation and transplantation, and one of its functions is to integrate and backup information regarding donation and transplantation through the National Transplant Registry System. In July 2015, 45 people were registered in the database of patients waiting for a heart transplant, of which 34.61% were female recipients and 65.39% male. Distribution and allocation processes are a key element to provide a fair distribution for those patients waiting for that organ; thus the creation of an electronic tool is proposed, one that aims to support the decision of the donation and/or transplants coordination committee by providing the necessary elements to make this process more efficient.


Subject(s)
Electronic Data Processing/organization & administration , Heart Transplantation/statistics & numerical data , Registries , Tissue Donors/supply & distribution , Tissue and Organ Procurement/organization & administration , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Databases, Factual , Female , Humans , Infant , Male , Mexico , Middle Aged , Young Adult
2.
J Chromatogr A ; 1218(41): 7365-70, 2011 Oct 14.
Article in English | MEDLINE | ID: mdl-21907993

ABSTRACT

Due to the impact in the media and the requirements of sensitivity and robustness, the detection of the misuse of forbidden substances in sports is a really challenging area for analytical chemistry, where any study focused on enhancing the performance of the analytical methods will be of great interest. The aim of the present study was to evaluate the usefulness of using hydrogen instead of helium as a carrier gas for the analysis of anabolic steroids by gas chromatography-mass spectrometry with electron ionization. There are several drawbacks related with the use of helium as a carrier gas: it is expensive, is a non-renewable resource, and has limited availability in many parts of the world. In contrast, hydrogen is readily available using a hydrogen generator or high-pressure bottled gas, and allows a faster analysis without loss of efficiency; nevertheless it should not be forgotten that due to its explosiveness hydrogen must be handled with caution. Throughout the study the impact of the change of the carrier gas will be evaluated in terms of: performance of the chromatographic system, saving of time and money, impact on the high vacuum in the analyzer, changes in the fragmentation behaviour of the analytes, and finally consequences for the limits of detection achieved with the method.


Subject(s)
Anabolic Agents/analysis , Androstanols/analysis , Gas Chromatography-Mass Spectrometry/instrumentation , Hydrogen/chemistry , Androsterone/analysis , Doping in Sports , Epitestosterone/analysis , Gas Chromatography-Mass Spectrometry/methods , Helium/chemistry , Testosterone/analysis
3.
Cells Tissues Organs ; 191(3): 240-7, 2010.
Article in English | MEDLINE | ID: mdl-19641292

ABSTRACT

The aim of this study was to investigate the effects of estradiol and follicle-stimulating hormone (FSH) on survival and growth of caprine preantral follicles. Pieces of ovarian tissue were cultured for 1 or 7 days in minimum essential medium (MEM) containing estradiol (1, 5, 10, 20 or 40 pg/ml), FSH (50 ng/ml), or a combination of the two hormones. Cultured and noncultured control ovarian tissues were processed for histological and ultrastructural studies. The results showed that after 7 days of culture, the treatments that yielded the highest percentage of normal follicles relative to MEM alone were those that combined FSH with estradiol at 1, 5 or 20 pg/ml. The addition of FSH to 1-day cultures containing 1 pg/ml estradiol or to 7-day cultures with 1 or 5 pg/ml estradiol increased the percentage of normal follicles compared to estradiol alone at the same concentrations. After 7 days of culture, all treatments generated higher percentages of developing follicles as compared to control and MEM alone. The addition of either FSH or 10 pg/ml of estradiol to the culture media or estradiol (1, 5, 10 or 20 pg/ml) and FSH in combination significantly increased follicular diameter as compared with MEM alone following 7 days of culture. Ultrastructural studies confirmed follicular integrity after 7 days of culture in the presence of 1 pg/ml estradiol plus FSH. In conclusion, this study demonstrated that the interaction between estradiol and FSH maintains ultrastructural integrity and stimulates activation and further growth of cultured caprine preantral follicles.


Subject(s)
Estradiol/administration & dosage , Follicle Stimulating Hormone/administration & dosage , Hormones/administration & dosage , Ovarian Follicle/drug effects , Ovarian Follicle/growth & development , Animals , Cell Culture Techniques , Cell Survival , Culture Media/chemistry , Dose-Response Relationship, Drug , Estradiol/chemistry , Female , Follicle Stimulating Hormone/chemistry , Goats , Hormones/chemistry , Microscopy, Electron, Transmission , Ovarian Follicle/ultrastructure , Time Factors
4.
Immunobiology ; 197(5): 478-93, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9413747

ABSTRACT

Macrophages (M phi) are important for angiogenesis during inflammation, wound repair, and tumor growth. However, well-characterized M phi subsets such as IFN-gamma-induced, classically activated (ca) M phi or IL-4/glucocorticoid-induced, alternatively activated (aa) M phi have not been thoroughly examined for a positive or negative association with angiogenesis. While caM phi populate early inflammatory reactions and high-turnover granulomas, aaM phi occur in healing wounds and chronic inflammation. In contrast to caM phi-dominated lesions, aaM phi-rich lesions are highly vascularized. In order to determine their angiogenic potential in vitro, these M phi subsets as well as unstimulated control macrophages (coM phi) were analyzed by RT-PCR for mRNA expression of 10 angiogenic factors after 3 and 6 days of culture. Early during activation, caM phi and coM phi expressed equal levels of 8 of 10 angiogenic factors (PDGF-A, MK, TNF-alpha, TGF-beta 1, PDGF-B, HGF, TGF-alpha, IGF-1), while aaM phi showed expression of only 4 of these factors (TGF-beta 1, PDGF-B, HGF, GF-1). After maturation, TGF-alpha and IGF-1 showed a shift in mRNA expression from caM phi to aaM phi resulting in a considerably enhanced expression of these factors in day-6 aaM phi as compared to day-6 caM phi and coM phi while PDGF-A, MK, and TNF-alpha remained suppressed in day 6 aaM phi. In all M phi subsets including controls, mRNA expression of aFGF and bFGF was minimal or absent while TGFG-beta 1, HGF, and ODGF-B were constitutively expressed. In order to functionally integrate angiogenic factor mRNA expression profiles, mitogenic activity of M phi subsets towards microvascular endothelium was assessed by cocultivation. Coculture experiments revealed that endothelial proliferation induced by aaM phi was 3.0-3.5x higher than induced by caM phi. In conclusion, mature aaM phi are well equipped to play an important role in protracted M phi-associated angiogenic processes. Presumably due to expression of predominantly angio-inhibitory cytokines such as TNF-alpha by caM phi but much less by aaM phi, caM phi exhibit only a low angiogenic potential in vitro and in vivo despite considerable expression of angiogenic factor mRNA.


Subject(s)
Growth Substances/biosynthesis , Macrophage Activation , Neovascularization, Physiologic , Nerve Growth Factors , Angiogenesis Inducing Agents/biosynthesis , Angiogenesis Inducing Agents/genetics , Cell Differentiation/drug effects , Cells, Cultured , Child , Child, Preschool , Coculture Techniques , Dexamethasone/pharmacology , Endothelium, Vascular/cytology , Gene Expression Regulation/drug effects , Growth Substances/genetics , Humans , Infant , Infant, Newborn , Interferon-gamma/pharmacology , Interleukin-4/pharmacology , Macrophage Activation/drug effects , Midkine , Monocytes/drug effects , Polymerase Chain Reaction , Protein Biosynthesis , Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Recombinant Proteins/pharmacology , Skin/blood supply , Tumor Cells, Cultured
5.
Hautarzt ; 48(2): 122-6, 1997 Feb.
Article in German | MEDLINE | ID: mdl-9173059

ABSTRACT

Superior vena cava syndrome (VCSS) develops because of a progressive reduction of venous return from the head, neck and the upper extremities. The presenting sign of this relatively rare condition is often a rapidly developing, often massive facial edema. As a consequence, such the patients are often seen initially by a dermatologist. Other clinical characteristics may include cyanotic facial erythema, dilatation of the neck veins, and a prominent venous pattern n the anterior chest. Today, primary lung cancers and other mediastinal tumours represent the most common cause of VCSS, which may take a slowly progressive or a more fulminant course. In these cases, the disease develops rapidly and becomes life-threatening, requiring intensive medial diagnosis and care. We describe three patients with superior vena cava syndrome due to a) bronchogenic carcinoma, b) bihilar sarcoidosis and c) metastasizing malignant melanoma. Since recognition of VCSS broadens the diagnostic spectrum of the dermatologist, an overview on its diagnostic and therapeutic implications is given based on our cases and the literature.


Subject(s)
Facial Dermatoses/diagnosis , Superior Vena Cava Syndrome/diagnosis , Aged , Carcinoma, Bronchogenic/complications , Carcinoma, Bronchogenic/diagnosis , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnosis , Diagnosis, Differential , Facial Dermatoses/etiology , Female , Humans , Lung Neoplasms/complications , Lung Neoplasms/diagnosis , Male , Mediastinal Neoplasms/complications , Mediastinal Neoplasms/diagnosis , Mediastinal Neoplasms/secondary , Melanoma/complications , Melanoma/diagnosis , Melanoma/secondary , Middle Aged , Sarcoidosis, Pulmonary/complications , Sarcoidosis, Pulmonary/diagnosis , Skin Neoplasms/complications , Skin Neoplasms/diagnosis , Superior Vena Cava Syndrome/etiology
6.
Arch Dermatol Res ; 285(6): 347-51, 1993.
Article in English | MEDLINE | ID: mdl-8105755

ABSTRACT

The effects of hydrocortisone, dexamethasone, betamethasone 17-valerate and clobetasol propionate at concentrations of 10(-5)-10(-12) M on the proliferation of human dermal microvascular endothelial cells (HDMEC) were studied in vitro. In addition, confluent HDMEC were treated with TNF (1000 U/ml) or IL-1 beta (1000 U/ml) alone or in combination with the corticosteroids (10(-5) M, 10(-6) M) for 24 h, and cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) was assessed by immunocytochemistry. Controls were treated either with growth medium or with the corticosteroids alone. All tested corticosteroids stimulated HDMEC growth after 4 and 6 days of treatment in a dose-dependent manner, as assessed by 3H-thymidine incorporation and the 4-methyl-umbelliferyl heptanoate (MUH) assay. The minimal effective concentration was 10(-9) M for hydrocortisone, 10(-10) M for dexamethasone and betamethasone, and 10(-12) M for clobetasol. In untreated and in corticosteroid-treated cultures, less than 5% of the cells expressed ICAM-1. TNF and IL-1 beta were strong inducers of ICAM-1 expression on 74% and 82% of the cells, respectively. None of the tested corticosteroids significantly influenced cytokine-induced ICAM-1 expression, suggesting that the anti-inflammatory effects of corticosteroids are not related to ICAM-1 modulation on HDMEC.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Skin/drug effects , Betamethasone Valerate/adverse effects , Cell Adhesion Molecules/biosynthesis , Cell Division/drug effects , Cells, Cultured , Clobetasol/adverse effects , Clobetasol/analogs & derivatives , Dexamethasone/adverse effects , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Humans , Hydrocortisone/adverse effects , Intercellular Adhesion Molecule-1 , Interleukin-1/pharmacology , Recombinant Proteins/pharmacology , Skin/blood supply , Skin/cytology , Telangiectasis/chemically induced , Telangiectasis/pathology , Tumor Necrosis Factor-alpha/pharmacology
7.
J Invest Dermatol ; 99(5): 531-6, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1431212

ABSTRACT

The effects of lipopolysaccharide (LPS), recombinant human tumor necrosis factor-alpha (TNF), recombinant human interleukin 1-beta (IL-1 beta), and interferon-gamma (IFN-gamma) on IL-6 production were determined by enzyme-linked immunosorbent assay (ELISA) and by Northern blot analysis in cultured human dermal microvascular endothelial cells (HDMEC). Unstimulated HDMEC did not produce significant amounts of IL-6, whereas lipopolysaccharide (LPS), TNF, and IL-1 beta were potent inducers of HDMEC-derived IL-6 production. Treatment with IFN-gamma had no effect. IL-1 beta stimulation resulted in pronounced IL-6 production after 4 h, followed by complete downregulation at the transcriptional level after 24 h. In contrast, LPS and TNF induced prolonged stimulation of IL-6 production by HDMEC as IL-6 mRNA transcripts were still detected after 24 h treatment and IL-6 protein was markedly increased at this timepoint. The effects of hydrocortisone, dexamethasone, calcitriol, acitretin, and cyclosporin A on TNF- or IL-1 beta-induced IL-6 production by HDMEC were determined by ELISA. Both hydrocortisone and dexamethasone dose-dependently inhibited the cytokine-induced IL-6 production, whereas the inhibition by calcitriol was less pronounced. In contrast, acitretin and cyclosporine A had no influence on cytokine-induced HDMEC IL-6 production. These results disclose dermal endothelial cells as a major source for the pro-inflammatory cytokine IL-6, involved in the regulation of inflammatory skin processes. As IL-6 seems to play a key role in the pathogenesis of psoriasis, the beneficial effects of corticosteroids and calcitriol in this disease may partly be explained by their ability to inhibit HDMEC-derived IL-6 production.


Subject(s)
Calcitriol/pharmacology , Cytokines/pharmacology , Dexamethasone/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Hydrocortisone/pharmacology , Interleukin-6/metabolism , Acitretin/therapeutic use , Cyclosporine/therapeutic use , Cytokines/antagonists & inhibitors , Drug Therapy, Combination , Endothelium, Vascular/cytology , Humans , Infant , Infant, Newborn , Interleukin-1/pharmacology , Male , Microcirculation/cytology , Psoriasis/chemically induced , Psoriasis/drug therapy , Skin/blood supply , Tumor Necrosis Factor-alpha/pharmacology
8.
J Invest Dermatol ; 98(2): 147-53, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1346267

ABSTRACT

The effects of recombinant human interleukin 1 alpha (IL-1 alpha), interleukin 1 beta (IL-1 beta), interleukin 6 (IL-6), granulocyte/macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) on the cell proliferation and the expression of intercellular adhesion molecule-1 (ICAM-1) were assessed in cultured human dermal microvascular endothelial cells (HDMEC). IL-1 alpha and IL-1 beta stimulated the proliferation of HDMEC in a dose-dependent manner, whereas in control experiments using human umbilical vein endothelial cells (HUVEC), IL-1 alpha and IL-1 beta did not stimulate HUVEC growth. Also GM-CSF stimulated the proliferation of HDMEC, whereas IL-6 did not affect endothelial cell growth in vitro. Treatment with IL-1 alpha, IL-1 beta, and TNF markedly increased the expression of ICAM-1 on HDMEC in a time- and dose-dependent manner, in contrast to IL-6 and GM-CSF. By pre-embedding immunoelectron microscopy, membrane-bound expression of ICAM-1 was visualized with pronounced labeling in areas of microvillous cell protrusions. The TNF-induced expression of ICAM-1 on HDMEC was blocked by co-incubation with a neutralizing antibody against TNF, but not with neutralizing antibodies against IL-1 alpha, IL-1 beta, or IL-6. In addition, co-incubation of HDMEC with TNF and the retinoid compound acitretin, dexamethasone, or indomethacin did not abrogate the TNF-induced ICAM-1 expression. These results disclose IL-1 as a major, multifunctional endothelial cell-targeted cytokine and further confirm the concept that pro-inflammatory cytokines exert differential regulatory effects on dermal microvascular endothelial cell proliferation and expression of cell-adhesion molecules.


Subject(s)
Cell Adhesion Molecules/physiology , Cytokines/pharmacology , Endothelium, Vascular/cytology , Skin/blood supply , Adult , Cell Adhesion Molecules/drug effects , Cell Division/drug effects , Child , Endothelium, Vascular/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Infant, Newborn , Intercellular Adhesion Molecule-1 , Interleukin-1/pharmacology , Interleukin-6/pharmacology , Male , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...